TokenPost·
CG Oncology Shares Rise About 9% After Phase 3 Bladder Cancer Data

The data involved cretostimogene grenadenorepvec, an adjuvant intravesical immunotherapy for non-muscle invasive bladder cancer.
Every crypto headline. One feed. Updated every minute.

The data involved cretostimogene grenadenorepvec, an adjuvant intravesical immunotherapy for non-muscle invasive bladder cancer.